Anavex Life Sciences Corp (AVXL)

[Gator328]

iHub is a terrible metric for determining stock price value. There's a reason you'll never see the words "InvestorsHub" in any of Buffett's shareholder letters.


I'd suggest CAPM or Dividend Discount Model for easy guidelines of established companies, or for early stage biotechs like Anavex, a risk-adjusted NPV using a 10-25% discount rate depending on whether the biotech is in early, middle, or late state growth.

Most posts are for entertainment value only. It's a giant puzzle and all the posters here are looking for the next piece that fits. Every now and then someone will post something worthwhile that provides a clearer picture.

I am not familiar with Five Prime Therapuetics but its iHub activity or lack thereof should have zero bearing on its stock price. Same goes with Anavex.